AMA Releases CPT® 2014 Updates
The American Medical Association (AMA) released on June 6 a handful of new or revised CPT® Category II codes.
A change to an existing code under Patient History was implemented January 1, 2014:
VTM5* criteria for major depressive disorder documented at the initial evaluation (MDD, MDD ADOL)
Under Diagnostic/Screening Processes or Results, two Category II codes will be implemented July 1, 2014:
3125F Esophageal biopsy report with a statement about dysplasia (present, absent, or indefinite) (PATH)
3126F Esophageal biopsy report with a statement about dysplasia (present, absent, or indefinite, and if present, contains appropriate grading) (PATH)
And two Category II codes, also under Diagnostic/Screening Processes or Results, were implemented April 1, 2014:
3775F Adenoma(s) or other neoplasm detected during screening colonoscopy (SCADR)
3776F Adenoma(s) or other neoplasm not detected during screening colonoscopy (SCADR) [emphasis added]
The AMA also announced June 5 that the FDA approval pending indicator was removed from vaccine codes 90687 Influenza virus vaccine, quadrivalent, split virus, when administered to children 6-35 months of age, for intramuscular use and 90688 Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use for CPT® 2014.
These new codes and code changes will first appear in the CPT® 2015 codebook. Until then, for future reference, you can go to www.ama-assn.org website to download the CPT® Category II Codes and Category I Vaccine Codes documents.
Tip: Start dates for late release codes may vary from payer to payer and may differ from the AMA implementation dates. Verify specific payer information regarding use of these codes.
Latest posts by Renee Dustman (see all)
- OIG Adds Items to Web-based Work Plan - August 15, 2017
- 3-Day Rule Noncompliance Costs NGS and N.E. Providers - August 10, 2017
- CAPG Comments on 2018 QPP Proposed Rule - August 9, 2017